This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
MMP3 · Western blot design guide
Design a Western Blot for MMP3
Real validated MMP3 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-MMP3 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Last reviewed: May 2026 · Scientific review: Boster Bio technical team
MMP3 Western Blot Experimental Design Guide
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | ~54 kDa | |
| Observed band | 54 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
Important caveats
Reasons your observed band may differ from the expected size.
| PTM | Cleaved | |
| Caveat | Zymogen activation state | |
| Regulation | Coagulation | |
| Isoform | 1 isoform(s) |
Section 1
Real Curated MMP3 Western Blot Protocols
Literature-validated Western blot parameters for MMP3 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | cultured cells (HT-3, HeLa) |
| Membrane | PVDF |
| Blocking | 5% non-fat milk, 1 hour |
| Primary incubation | overnight at 4°C |
| Secondary incubation | 1 h |
| Wash | TBST, three times |
| Detection | ECL Fluorescence Assay Kit |
| Exposure / imaging | gel imager |
Section 2
What Is the Expected MMP3 Western Blot Band Size?
MMP3 has a 54 kDa predicted and observed pro-enzyme band, though proteolytic removal of its ~9 kDa propeptide during activation can shift the mature band down to ~45 kDa.
| Single band at 54 kDa in tissue or whole-cell lysate | Matches the predicted mass of full-length pro-MMP3, consistent with an unmodified zymogen that carries no glycosylation |
| Smaller band near 45 kDa alongside or instead of the 54 kDa band | Reflects the mature, activated form of MMP3 after proteolytic removal of the ~9 kDa propeptide (residues 18-99) |
| Weak or absent band in whole-cell lysate alone | MMP3 is secreted into the extracellular space and ECM, so intracellular lysates capture little of the mature secreted pool |
| No shift in band position between reducing and non-reducing gels | The single disulfide bond is intrachain, stabilizing the hemopexin-like domain rather than linking two separate chains, so no dimer band forms |
| Sharp single band without smearing | MMP3 has no annotated glycosylation sites, so it migrates as a homogeneous, non-glycosylated species |
| Recombinant or truncated protein standard running near 36 kDa | Bacterially expressed or truncated constructs lack the full domain structure and any post-translational processing seen in native protein, so they run lower than the 54 kDa native form |
💡Expected MMP3 appearanceExpect a single ~54 kDa band for full-length pro-MMP3 in tissue or whole-cell lysate, matching its predicted mass since MMP3 has no glycosylation; a smaller ~45 kDa band can appear once the propeptide is proteolytically removed.
| Predicted mass (54 kDa, 477 aa) | Sets the baseline single-band size seen in native tissue and whole-cell lysates |
| Signal peptide cleavage (residues 1-17) | Removed co-translationally from the secreted precursor, so it does not affect the mass of the mature secreted species seen on blot |
| Propeptide cleavage (residues 18-99) | Removal of this ~9 kDa prodomain during zymogen activation converts the ~54 kDa proenzyme to a smaller ~45 kDa mature/active band |
| Intrachain disulfide bond (Cys290-Cys477) | Stabilizes the hemopexin-like domain fold within a single chain rather than linking separate chains, so it does not produce a higher-molecular-weight dimer band |
| Secreted/extracellular localization | Shifts most full-length protein into conditioned media or ECM fractions, reducing band intensity in standard whole-cell lysate preparations |
| Non-glycosylated recombinant/bacterial standard | Runs lower than native tissue-derived protein since it lacks any post-translational modification or full-length processing beyond the core expressed sequence |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | MMP3 is secreted into the extracellular space/ECM, leaving little full-length protein inside whole-cell lysates | Test conditioned media, ECM extracts, or concentrated secretome samples alongside whole-cell lysate |
| Band lower than expected | The propeptide (residues 18-99) has been proteolytically removed, converting the ~54 kDa zymogen to the ~45 kDa mature active form | Confirm which form the antibody epitope targets and include pro- vs active-MMP3 controls to distinguish normal processing from degradation |
| Multiple bands | The ~54 kDa pro-form and the ~45 kDa mature/active form can both be present in samples with active MMP3 turnover | Compare relative band intensities across time points or use activator/inhibitor treatments to confirm a pro-to-active conversion pattern |
| Weak or no signal | Low steady-state levels of secreted MMP3 in standard lysates, or loss of antibody epitope if the propeptide or hemopexin region is removed | Increase protein loading, concentrate the secreted fraction, and verify the antibody epitope location relative to known processing sites |
| Fragments below expected size | Proteolytic cleavage at the propeptide junction or within the hemopexin-like domain can generate smaller fragments distinct from the full-length or mature bands | Add protease inhibitors during lysis and compare fresh versus stored samples to rule out post-lysis degradation |
Experiment evidence
Western blot images showing MMP3 band
PB9267 · MMP3
PB9267 · MMP3
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for MMP3 Western blot
🧪For positive controls for MMP3 in Western blot, you can use recombinant MMP3 protein or conditioned medium from a cell line known to secrete MMP3, since no Human Protein Atlas expression data is available to identify a validated positive tissue or cell line for this target.
Positive control: Recombinant MMP3 protein / conditioned medium
Negative control: ubiquitously expressed; use siRNA knockdown or KO line
Loading controls: Run GAPDH and β-actin alongside a total-protein stain (stain-free imaging, Ponceau S, or REVERT) to confirm equal loading and transfer.
⚠️Feasibility: As a secreted protein with no Human Protein Atlas expression data available, MMP3 is poorly suited to whole-cell lysate controls; conditioned medium or recombinant protein plus an siRNA/KO negative control is a more reliable approach.
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|
Section 3
Advanced MMP3 Western Blot Tips
Deeper troubleshooting and optimisation questions for MMP3, answered from its protein features.
Why might the MMP3 band shift from predicted 54 kDa?
MMP3 is synthesized as a 54 kDa zymogen with a signal peptide (1-17) and propeptide (18-99). Proteolytic removal of the propeptide during activation yields a smaller ~45 kDa active enzyme, so blots can show both a full-length precursor band near 54 kDa and a lower-molecular-weight active form, rather than one single band at the predicted mass.
Does MMP3 have isoforms that affect band pattern?
UniProt lists only one MMP3 isoform, with no alternative splice variants annotated. A single ~54 kDa precursor band is expected from primary sequence; additional bands are more likely due to zymogen-to-active processing (propeptide removal) than to isoform-specific sequence differences.
Is MMP3 expression induced under inflammatory or ECM-remodeling conditions?
MMP3 is annotated with innate immunity and collagen degradation keywords, consistent with its role as an inflammation-responsive matrix metalloproteinase. Expression is typically upregulated during ECM remodeling and innate immune activation, so treated or stimulated samples may show stronger 54 kDa zymogen bands than untreated controls.
What transfer method to use for MMP3 Western blot?
At a predicted 54 kDa with no glycosylation annotated, MMP3 transfers efficiently with standard wet or semi-dry transfer onto PVDF or nitrocellulose, typically 100V for about 60-90 minutes or per semi-dry manufacturer settings. No extended transfer times are needed since the protein is not high molecular weight or heavily modified.
How should extra bands below 54 kDa be interpreted?
Because MMP3 is proteolytically processed, removal of the 18-99 propeptide generates an active enzyme smaller than the 54 kDa zymogen. Bands below 54 kDa likely represent active or partially processed MMP3 rather than nonspecific binding, especially if intensity increases with activating treatments or decreases with protease inhibitors.
Should MMP3 samples be run reducing or non-reducing?
MMP3 contains one annotated disulfide bond and is not reported to oligomerize. Reducing conditions (with DTT or beta-mercaptoethanol) are recommended to break this disulfide bond and denature the protein fully, giving consistent monomeric migration near the predicted 54 kDa mass and avoiding variable non-reduced mobility shifts.
Why might MMP3 appear in nuclear or cytoplasmic fractions?
Although MMP3 is primarily secreted to the extracellular matrix, UniProt also annotates nuclear and cytoplasmic localization (PubMed:35940311). Fractionated lysates may therefore show MMP3 bands outside conditioned media or membrane fractions; this should be treated as a genuine localization finding rather than an extraction artifact.
How to quantitate total MMP3 across pro and active forms?
Since activation converts the 54 kDa zymogen into a smaller active fragment, total MMP3 signal is the sum of precursor and active bands unless the antibody epitope lies only within the propeptide. Normalize combined signal to a loading control, and quantify pro- and active-form bands separately if activation state matters.
Boster reagents
Best MMP3 Western Blot Antibodies
BosterBio's MMP3 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Real WB data
Anti-MMP3 Antibody Picoband®
Cat # PB9267
The anti-MMP3 antibodies recommended below are top-performing, extensively cited reagents validated through rigorous testing, including orthogonal confirmation against negative tissue controls and complementary methods, ensuring specific, reproducible Western blot detection of MMP3 you can trust for your experiments.
Which to pick: Only one Boster anti-MMP3 antibody is catalogued, PB9267 (Picoband), so it's the clear choice. It has a genuine WB validation image showing a specific 36 kDa band on recombinant human MMP3 protein at 0.5 ug/ml.
Source: BosterBio MMP3 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.
References
- UniProt Consortium. UniProt entry P08254.
- Human Protein Atlas. MMP3 tissue expression.